NOVARTIS PHARMA GMBH has a total of 44 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and optics are CELGENE CORP, ASTA PHARMACEUTICALS CO LTD and RECORDATI AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 23 | |
#2 | China | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Austria | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 | |
#9 | Mexico | 1 | |
#10 | Serbia | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Optics | |
#4 | Biotechnology | |
#5 | Machines | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Welzel Dieter | 6 |
#2 | Schoch Christian | 3 |
#3 | Fetz Andrea | 3 |
#4 | Bizec Jean-Claude | 3 |
#5 | Kaupmann Klemens | 2 |
#6 | Saunier Maggy Babiole | 2 |
#7 | Francis Charles Auxilium | 2 |
#8 | Turek Richard Charles | 2 |
#9 | Mishina Tadashi | 1 |
#10 | Streiff Markus | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007227602A1 | Heterocyclic organic compounds for the treatment of in particular melanoma | |
AU2002331180A1 | Nogo receptor homologues and their use | |
AU2002317824A1 | Novel g-protein coupled receptors and dna sequences thereof | |
AU2002345015A1 | Ophthalmic once-a-day composition | |
AU2002304784A1 | Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer | |
AU2002219227A1 | Holographic multifocal lens | |
EP1346253A2 | Contact lens with opaque iris pattern | |
BR9916495A | Use of 5ht3-receptor-antagonists |